selected scholarly activity
-
conferences
- HIGHER VINCRISTINE DOSES CORRELATE WITH LONGER OVERALL SURVIVAL: A POST-HOC ANALYSIS OF PARTICIPANTS RECEIVING PCV ON RTOG 9402. Neuro-Oncology. 2023
- Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539.. Neuro-Oncology. 137-145. 2023
- Patterns of Failure after Stereotactic Radiosurgery vs. Whole Brain Radiotherapy for Resected Brain Metastases: Central Imaging Review of the N107C/CEC.3 (Alliance) Phase III Clinical Trial. International Journal of Radiation Oncology Biology Physics. 1063-1064. 2022
- Effect of Stereotactic Radiosurgery Compared to Whole-brain Radiotherapy for Limited Brain Metastasis on Long Term Cognition and Quality of Life: A Pooled Analysis of NCCTG N107C/CEC.3 and N0574 (Alliance) Randomized Clinical Trials. International Journal of Radiation Oncology Biology Physics. S175-S176. 2020
- Local Control After Resection And Adjuvant Radiosurgery Compared To Radiosurgery Alone For Brain Metastasis: Exploratory Analysis Of Alliance NCCTG N107C. International Journal of Radiation Oncology Biology Physics. e749-e750. 2020
- Steep Dose-response Relationship between Maximum Hippocampal Dose and Memory Deficits following Hippocampal Avoidance Whole Brain Radiation Therapy (HA-WBRT) for Brain Metastases: A Secondary Analysis of NRG/RTOG 0933. International Journal of Radiation Oncology Biology Physics. S176-S176. 2020
- EP584 Circulating tumour DNA to monitor tumour activity in endometrial cancer. International Journal of Gynecological Cancer. A348-A349. 2019
- EP610 Investigation of patient acceptability of ctDNA in endometrial cancer follow-up. International Journal of Gynecological Cancer. A358-A359. 2019
- FINAL RESULTS WITH CHEMORADIOTHERAPY FOR ANAPLASTIC OLIGODENDROGLIAL TUMORS FROM NRG ONCOLOGY/RTOG 9402. Neuro-Oncology. 15-15. 2019
- Optimizing Whole Brain Radiotherapy Dose and Fractionation: Results from a Prospective Phase III Trial (NCCTG N107C (Alliance)/CEC.3). International Journal of Radiation Oncology Biology Physics. S10-S10. 2019
- CE7 CANADIAN CLINICAL TRIALS GROUP / ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY. A PHASE III TRIAL OF STEREOTACTIC RADIOSURGERY COMPARED WITH WHOLE BRAIN RADIOTHERAPY (WBRT) FOR 5-15 BRAIN METASTASES. Neuro-Oncology. 49-49. 2017
- N107C/CEC.3: A Phase III Trial of Post-Operative Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease. International Journal of Radiation Oncology Biology Physics. 937-937. 2016
- Evaluation of Pseudoprogression in Patients With Glioblastoma (EPPIG). International Journal of Radiation Oncology Biology Physics. S288-S288. 2014
- Stereotactic Radiosurgery for Refractory Trigeminal Neuralgia. International Journal of Radiation Oncology Biology Physics. S325-S326. 2014
- A Preliminary Series of the Use of Stereotactic Radiosurgery (SBRT) in High-Risk Head-and-Neck Cancer. International Journal of Radiation Oncology Biology Physics. S429-S430. 2013
- Robotic radiosurgery for the treatment of one to three brain metastases: A pragmatic application of cost-benefit analysis using willingness to pay.. Journal of Clinical Oncology. 17-17. 2012
- Fractionated Stereotactic Radiosurgery with Concurrent Temozolomide for Locally Recurrent Glioblastoma Multiforme: A Prospective Study. International Journal of Radiation Oncology Biology Physics. S281-S281. 2011
- CNS atypical teratoid rhabdoid tumor (ATRT) in children less than 36 months: A Canadian pediatric brain tumor consortium (CPBTC) experience. Neuro-Oncology. 370-370. 2008
- Spinal cord tumors in infancy: A Canadian pediatric brain tumor consortium report. Neuro-Oncology. 416-416. 2008
- 43 Self-shielding character of a tomotherapy unit in a replacement strategy: Economic considerations. Radiotherapy and Oncology. S13-S13. 2006
- PCN27 HEALTH STATUS MEASURES AS PREDICTORS OF MORTALITY AMONG ADULTS WITH BRAIN TUMORS. Value in Health. A112-A112. 2006
- Self-reported comprehensive health status of adult brain tumor patients using the Health Utilities Index. Cancer. 258-265. 1997
- ENDOCRINE DISORDERS FOLLOWING TREATMENT OF BRAIN-TUMORS IN CHILDHOOD. British Journal of Cancer. 874-874. 1987
- GROWTH FAILURE FOLLOWING IRRADIATION IN CHILDREN WITH BRAIN-TUMORS. British Journal of Cancer. 865-866. 1987
- HIGH-DOSE BCNU PRIMARY CHEMOTHERAPY WITH FULL DOSE RADIOTHERAPY FOR ASTROCYTOMA GRADE-IV. British Journal of Cancer. 341-341. 1987
- THE EFFECT OF RADIOTHERAPY ON TC-99M HMPAO DISTRIBUTION IN BRAIN-TUMORS - INITIAL RESULTS. Journal of Nuclear Medicine. 1030-1030. 1986
-
journal articles
- QOL-18. HIGHER VINCRISTINE DOSES CORRELATE WITH LONGER OVERALL SURVIVAL: A POST-HOC ANALYSIS OF PARTICIPANTS RECEIVING PCV ON RTOG 9402. Neuro-Oncology. 25:v252-v252. 2023
- Spindle cell oncocytoma reclassified from amelanotic melanocytoma of the sellar region. Clinical Neuropathology. 42:197-200. 2023
- Surgical Management of Meningiomas Involving the Torcula, Transverse Sinus, and Jugular Bulb: A Technical Note and Review of the Literature. Journal of Neurological Surgery Reports. 84:e92-e102. 2023
- Association of circulating markers with cognitive decline after radiation therapy for brain metastasis. Neuro-Oncology. 25:1123-1131. 2023
- Corrigendum to: Association of circulating markers with cognitive decline after radiation therapy for brain metastasis. Neuro-Oncology. 25:1010-1010. 2023
- Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539. Neuro-Oncology. 25:137-145. 2023
- Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis. JAMA Oncology. 8:1809-1809. 2022
- Hypofractionated Stereotactic Radiotherapy for the Treatment of Benign Intracranial Meningiomas: Long-Term Safety and Efficacy. Current Oncology. 28:3683-3691. 2021
- A pilot study of stereotactic boost for malignant epidural spinal cord compression: clinical significance and initial dosimetric evaluation. Radiation Oncology. 15:267. 2020
- CTNI-01. EFFECT OF STEREOTACTIC RADIOSURGERY COMPARED TO WHOLE-BRAIN RADIOTHERAPY FOR LIMITED BRAIN METASTASIS ON LONG TERM COGNITION AND QUALITY OF LIFE: A POOLED ANALYSIS OF RANDOMIZED CLINICAL TRIALS. Neuro-Oncology. 22:ii40-ii41. 2020
- CTNI-57. LOW-RISK MENINGIOMA: OUTCOMES FROM NRG ONCOLOGY/RTOG 0539. Neuro-Oncology. 22:ii55-ii56. 2020
- CTNI-01. EFFECT OF STEREOTACTIC RADIOSURGERY COMPARED TO WHOLE-BRAIN RADIOTHERAPY FOR LIMITED BRAIN METASTASIS ON LONG TERM COGNITION AND QUALITY OF LIFE: A POOLED ANALYSIS OF RANDOMIZED CLINICAL TRIALS. Neuro-Oncology. 22:ii40-ii41. 2020
- CTNI-57. LOW-RISK MENINGIOMA: OUTCOMES FROM NRG ONCOLOGY/RTOG 0539. Neuro-Oncology. 22:ii55-ii56. 2020
- 25. EFFECT OF STEREOTACTIC RADIOSURGERY COMPARED TO WHOLE-BRAIN RADIOTHERAPY FOR LIMITED BRAIN METASTASIS ON LONG TERM COGNITION AND QUALITY OF LIFE: A POOLED ANALYSIS OF NCCTG N107C/CEC.3 AND N0574 (ALLIANCE) RANDOMIZED CLINICAL TRIALS. NOA. 2:ii4-ii4. 2020
- 25. EFFECT OF STEREOTACTIC RADIOSURGERY COMPARED TO WHOLE-BRAIN RADIOTHERAPY FOR LIMITED BRAIN METASTASIS ON LONG TERM COGNITION AND QUALITY OF LIFE: A POOLED ANALYSIS OF NCCTG N107C/CEC.3 AND N0574 (ALLIANCE) RANDOMIZED CLINICAL TRIALS. Neuro-Oncology Advances. 2:ii4-ii4. 2020
- Radiation Necrosis Following Stereotactic Radiosurgery for Trigeminal Neuralgia. Canadian Journal of Neurological Sciences. 47:425-427. 2020
- Erratum to: Trifiletti DM, Ballman KV, Brown PD, Anderson SK, Carrero XW, Cerhan JH, Whitton AC, Greenspoon J, Parney IF, Laack NN, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG II, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D. Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3). Int J Radiat Oncol Biol Phys 2020;106:255-260.. International Journal of Radiation Oncology Biology Physics. 106:1111-1111. 2020
- Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3). International Journal of Radiation Oncology Biology Physics. 106:255-260. 2020
- ACTR-13. FINAL RESULTS WITH CHEMORADIOTHERAPY FOR ANAPLASTIC OLIGODENDROGLIAL TUMORS FROM NRG ONCOLOGY/RTOG 9402. Neuro-Oncology. 21:vi15-vi15. 2019
- ACTR-13. FINAL RESULTS WITH CHEMORADIOTHERAPY FOR ANAPLASTIC OLIGODENDROGLIAL TUMORS FROM NRG ONCOLOGY/RTOG 9402. Neuro-Oncology. 21:vi15-vi15. 2019
- 105 Cyberknife Stereotactic Radiosurgery for Treatment of Benign Intracranial Meningioma: Long-Term Safety and Efficacy. Radiotherapy and Oncology. 139:S46-S47. 2019
- The Future Is Now—Prospective Study of Radiosurgery for More Than 4 Brain Metastases to Start in 2018!. Frontiers in Oncology. 8:380. 2018
- CMET-48. CE7 CANADIAN CLINICAL TRIALS GROUP / ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY. A PHASE III TRIAL OF STEREOTACTIC RADIOSURGERY COMPARED WITH WHOLE BRAIN RADIOTHERAPY (WBRT) FOR 5–15 BRAIN METASTASES. Neuro-Oncology. 19:vi49-vi49. 2017
- NCOG-06. N107C/CEC.3 (ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY/CANADIAN CANCER TRIALS GROUP): PHASE III TRIAL OF POST-OPERATIVE RADIOSURGERY COMPARED WITH WHOLE BRAIN RADIOTHERAPY FOR RESECTED METASTATIC BRAIN DISEASE: COGNITIVE FUNCTION OF LONG-TERM SURVIVORS. Neuro-Oncology. 19:vi138-vi138. 2017
- Amelanotic melanocytoma of the sella mimicking pituitary adenoma. Clinical Neuropathology. 36:283-287. 2017
- NCOG-06. N107C/CEC.3 (ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY/CANADIAN CANCER TRIALS GROUP): PHASE III TRIAL OF POST-OPERATIVE RADIOSURGERY COMPARED WITH WHOLE BRAIN RADIOTHERAPY FOR RESECTED METASTATIC BRAIN DISEASE: COGNITIVE FUNCTION OF LONG-TERM SURVIVORS. Neuro-Oncology. 19:vi138-vi138. 2017
- Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial. The Lancet Oncology. 18:1049-1060. 2017
- Evaluation of pseudoprogression in patients with glioblastoma. Neuro-Oncology Practice. 4:120-134. 2017
- 65‐year‐old female with cerebellopontine angle lesion. Brain Pathology. 27:237-238. 2017
- Exploration of Morbidity in a Serial Study of Long-Term Brain Tumor Survivors: A Focus on Pain. Journal of Adolescent and Young Adult Oncology. 4:129-136. 2015
- Health-related Quality of Life in Long-term Survivors of Brain Tumors in Childhood and Adolescence. Journal of Pediatric Hematology/Oncology. 37:362-367. 2015
- Clival chordoma metastatic to right lateral ventricle: A case report. Canadian Journal of Neurological Sciences. 41:S15-S15. 2014
- Stereotactic radiosurgery for refractory trigeminal neuralgia. Canadian Journal of Neurological Sciences. 41:S15-S15. 2014
- Fractionated stereotactic radiosurgery with concurrent temozolomide chemotherapy for locally recurrent glioblastoma multiforme: a prospective cohort study. OncoTargets and Therapy. 7:485-485. 2014
- Robotic Radiosurgery for the Treatment of 1–3 Brain Metastases: A Pragmatic Application of Cost-Benefit Analysis Using Willingness-To-Pay. Technology in Cancer Research and Treatment. 12:517-523. 2013
- The Technique and Cost of Radiosurgery for the Treatment of 1-3 Brain Metastases. Canadian Journal of Neurological Sciences. 40:795-799. 2013
- Use of Continuous Infusion Pumps During Radiation Treatment. JCO Oncology Practice. 9:107-111. 2013
- Technology Resource Planning in Radiation Oncology: Application of a Needs-Based Analytic Framework to Radiosurgery Planning in Ontario. JCO Oncology Practice. 8:358-362. 2012
- Factors affecting the implementation of complex and evolving technologies: multiple case study of intensity-modulated radiation therapy (IMRT) in Ontario, Canada. BMC Health Services Research. 11:178. 2011
- Total quality culture in radiotherapy departments across Ontario. Radiotherapy and Oncology. 99:90-93. 2011
- 167 A PRELIMINARY INVESTIGATION OF TOTAL QUALITY CULTURE IN RADIOTHERAPY DEPARTMENTS ACROSS ONTARIO, CANADA: A PROVINCIAL SURVEY. Radiotherapy and Oncology. 92:S53-S53. 2009
- Organisational Standards for the Delivery of Intensity-modulated Radiation Therapy in Ontario. Clinical Oncology. 21:192-203. 2009
- The Utility of Publicly Reported Cancer Treatment Wait Time Information for Patients and Health Care Providers. Clinical Oncology. 21:218-225. 2009
- Health Status Measurements at Diagnosis As Predictors of Survival Among Adults With Brain Tumors. Journal of Clinical Oncology. 24:3636-3643. 2006
- Who are the users of publicly reported cancer treatment wait times (WT)?. Journal of Clinical Oncology. 24:6043-6043. 2006
- Importance of the mini-mental status examination in the treatment of patients with brain metastases: a report from the radiation therapy oncology group protocol 91-04. International Journal of Radiation Oncology Biology Physics. 48:59-64. 2000
- Health-related quality of life in survivors of tumours of the central nervous system in childhood—a preference-based approach to measurement in a cross-sectional study1Presented in part to the meetings of the International Society of Pediatric Oncology (SIOP) in Paris, September 1994 and Montevideo, October 1995.1. European Journal of Cancer. 35:248-255. 1999
- Accelerated radiation therapy for primary lymphoma of the brain. Radiotherapy and Oncology. 47:191-195. 1998
- Osteopenia in children surviving brain tumours. European Journal of Cancer. 34:873-877. 1998
- Author reply. Cancer. 82:995-996. 1998
- Self-reported comprehensive health status of adult brain tumor patients using the health utilities index. Cancer. 82:995-995. 1998
- A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: A report of the radiation therapy oncology group (RTOG) 9104. International Journal of Radiation Oncology Biology Physics. 39:571-574. 1997
- Self‐reported comprehensive health status of adult brain tumor patients using the Health Utilities Index. Cancer. 80:258-265. 1997
- 2022 Prognosis and management of oligodendrogliomas. International Journal of Radiation Oncology Biology Physics. 36:289-289. 1996
- Child with Wilms' tumor and von Willebrand disease at diagnosis and apparent complete response to chemotherapy after multiple relapses. Pediatric Blood and Cancer. 26:64-69. 1996
- Childhood medulloblastoma in Ontario, 1977–1987: Population-based results. Pediatric Blood and Cancer. 26:1-9. 1996
- Radiotherapy and adjuvant chemotherapy for childhood medulloblastoma. The Royal Marsden Hospital experience.. Strahlentherapie und Onkologie. 171:615-621. 1995
- Nitric oxide and anti-cancer therapy. Cancer Treatment Reviews. 21:159-181. 1995
- Abstracts of the 6th Canadian Neuro-Oncology Meeting May 18–21, 1994 Lake Louise, Alberta. Journal of Neuro-Oncology. 19:175-192. 1994
- An assessment of global health status in survivors of acute lymphoblastic leukemia in childhood.. Journal of Pediatric Hematology/Oncology. 15:284-290. 1993
- Medulloblastoma - Ontario provincial review (1977 – 1987). International Journal of Radiation Oncology Biology Physics. 27:263-263. 1993
- Phase I study of hyperfractionated whole brain irradiation (HWBI) in the treatment of primary cerebral lymphoma. Clinical Oncology. 5:159-164. 1993
- Disseminated Langerhans Cell Histiocytosis in Identical Twins Unresponsive to Recombinant Human α-Interferon and Total Body Irradiation. Journal of Pediatric Hematology/Oncology. 14:269-272. 1992
- Management of Children with Acute Lymphoblastic Leukemia by the Dana-Farber Cancer Institute Protocols. Journal of Pediatric Hematology/Oncology. 14:136-139. 1992
- Endocrine disorders following treatment of childhood brain tumours. British Journal of Cancer. 61:622-625. 1990
- Low grade glioma of the cerebral hemispheres in adults: a retrospective analysis of 88 cases. International Journal of Radiation Oncology Biology Physics. 18:783-786. 1990
- High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma. British Journal of Cancer. 58:779-782. 1988
- Initial experience with Tc-99m-HM-PAO in the study of brain tumors. European Journal of Nuclear Medicine and Molecular Imaging. 14:39-44. 1988
- The effect of storage conditions on amniotic fluid phosphatidylglycerol concentration.. Journal of Perinatology. 8:356-357. 1988
- Growth failure and other endocrine disorders following irradiation of childhood brain tumors. International Journal of Radiation Oncology Biology Physics. 13:88-88. 1987
- Combining backscattered electrons and low energy photons to improve the dose distribution to an eyelid. International Journal of Radiation Oncology Biology Physics. 11:617-620. 1985
- Radiotherapy for jugulo-tympanic paragangliomas (Glomus jugulare tumours). Journal of Laryngology and Otology. 98:621-629. 1984
- Hair Regrowth after Cancer Therapy. Human and Experimental Toxicology. 2:465-472. 1983
- Quantified scoring of the amniotic fluid surfactant foam test and assessment of factors contributing to false negative test results. American Journal of Obstetrics and Gynecology. 145:752-756. 1983